Deucravacitinib in plaque psoriasis: a profile of its use Arnold Lee Adis Drug Q&A 01 November 2023 Pages: 357 - 364
Ublituximab in relapsing forms of multiple sclerosis: a profile of its use Hannah A. Blair Adis Drug Q&A 06 November 2023 Pages: 365 - 372
Go with your gut: targeting the microbiome for treatment of irritable bowel syndrome Simon Fung Disease Management 23 September 2023 Pages: 373 - 377
Manage idiopathic hypersomnia with a combination of non-pharmacological and pharmacological treatments Arnold Lee Practical Issues and Updates 03 October 2023 Pages: 378 - 381
Towards intra-articular therapies for more than just symptom management in osteoarthritis Simon Fung Practical Issues and Updates 09 October 2023 Pages: 382 - 387
The role of belzutifan, an inhibitor of hypoxia-inducible factor, for renal cell carcinoma in adults with Von Hippel–Lindau disease: a review Anne M. SchwartzWaddih FakhreAlan D. Kaye Review Article 21 November 2023 Pages: 388 - 392